222 related articles for article (PubMed ID: 33770323)
21. Esthesioneuroblastoma - a clinicopathologic study and role of DNA topoisomerase alpha.
Sharma S; Sharma MC; Johnson MH; Lou M; Thakar A; Sarkar C
Pathol Oncol Res; 2007; 13(2):123-9. PubMed ID: 17607373
[TBL] [Abstract][Full Text] [Related]
22. Proposal of a TNM classification-based staging system for esthesioneuroblastoma: More precise prediction of prognosis.
Sun M; Wang K; Qu Y; Zhang J; Zhang S; Chen X; Wang J; Wu R; Zhang Y; Yi J; Xiao J; Xu G; Huang X; Luo J
Head Neck; 2021 Apr; 43(4):1097-1104. PubMed ID: 33301222
[TBL] [Abstract][Full Text] [Related]
23. Olfactory neuroblastoma: the University of Erlangen-Nuremberg experience 1975-2000.
Constantinidis J; Steinhart H; Koch M; Buchfelder M; Schaenzer A; Weidenbecher M; Iro H
Otolaryngol Head Neck Surg; 2004 May; 130(5):567-74. PubMed ID: 15138422
[TBL] [Abstract][Full Text] [Related]
24. Pattern of loco-regional relapses and treatment in pediatric esthesioneuroblastoma: The French very rare tumors group (Fracture) contribution.
Dumont B; Fresneau B; Claude L; Defachelles AS; Couloigner V; Puget S; Brisse HJ; Fréneaux P; Lacour B; Orbach D
Pediatr Blood Cancer; 2020 Apr; 67(4):e28154. PubMed ID: 31930719
[TBL] [Abstract][Full Text] [Related]
25. Optimal treatment and prognostic factors for esthesioneuroblastoma: retrospective analysis of 187 Chinese patients.
Xiong L; Zeng XL; Guo CK; Liu AW; Huang L
BMC Cancer; 2017 Apr; 17(1):254. PubMed ID: 28399835
[TBL] [Abstract][Full Text] [Related]
26. Olfactory Neuroblastoma.
Veyrat M; Vérillaud B; Fiaux-Camous D; Froelich S; Bresson D; Nicolai P; Herman P
Adv Otorhinolaryngol; 2020; 84():154-167. PubMed ID: 32731231
[TBL] [Abstract][Full Text] [Related]
27. Chemotherapy for advanced esthesioneuroblastoma: the Mayo Clinic experience.
McElroy EA; Buckner JC; Lewis JE
Neurosurgery; 1998 May; 42(5):1023-7; discussion 1027-8. PubMed ID: 9588546
[TBL] [Abstract][Full Text] [Related]
28. Endoscopic endonasal resection of esthesioneuroblastoma: A single center experience of 24 patients.
Feng L; Fang J; Zhang L; Li H; Zhou B; Chen X; Li Y; Han D
Clin Neurol Neurosurg; 2015 Nov; 138():94-8. PubMed ID: 26310690
[TBL] [Abstract][Full Text] [Related]
29. Management of orbital invasion in esthesioneuroblastoma: 14 years' experience.
Li R; Tian S; Zhu Y; Yan L; Zhu W; Quan H; Wang S
Radiat Oncol; 2019 Jun; 14(1):107. PubMed ID: 31196122
[TBL] [Abstract][Full Text] [Related]
30. Esthesioneuroblastoma: a Danish demographic study of 40 patients registered between 1978 and 2000.
Theilgaard SA; Buchwald C; Ingeholm P; Kornum Larsen S; Eriksen JG; Sand Hansen H
Acta Otolaryngol; 2003 Apr; 123(3):433-9. PubMed ID: 12737303
[TBL] [Abstract][Full Text] [Related]
31. Evaluating the prognostic potential of the Ki67 proliferation index and tumour-infiltrating lymphocytes in olfactory neuroblastoma.
Classe M; Burgess A; El Zein S; Wassef M; Herman P; Mortuaire G; Leroy X; Malouf GG; Verillaud B
Histopathology; 2019 Dec; 75(6):853-864. PubMed ID: 31306501
[TBL] [Abstract][Full Text] [Related]
32. Prognosis and biology in esthesioneuroblastoma: the emerging role of Hyams grading system.
Saade RE; Hanna EY; Bell D
Curr Oncol Rep; 2015 Jan; 17(1):423. PubMed ID: 25416317
[TBL] [Abstract][Full Text] [Related]
33. Patterns of failure and outcome in esthesioneuroblastoma.
Dias FL; Sa GM; Lima RA; Kligerman J; Leoncio MP; Freitas EQ; Soares JR; Arcuri RA
Arch Otolaryngol Head Neck Surg; 2003 Nov; 129(11):1186-92. PubMed ID: 14623748
[TBL] [Abstract][Full Text] [Related]
34. Esthesioneuroblastoma--what is the optimal treatment?
Eriksen JG; Bastholt L; Krogdahl AS; Hansen O; Joergensen KE
Acta Oncol; 2000; 39(2):231-5. PubMed ID: 10859017
[TBL] [Abstract][Full Text] [Related]
35. Combined modality therapy of esthesioneuroblastoma.
McLean JN; Nunley SR; Klass C; Moore C; Müller S; Johnstone PA
Otolaryngol Head Neck Surg; 2007 Jun; 136(6):998-1002. PubMed ID: 17547995
[TBL] [Abstract][Full Text] [Related]
36. Esthesioneuroblastoma: a Danish clinicopathological study of 40 consecutive cases.
Ingeholm P; Theilgaard SA; Buchwald C; Hansen HS; Francis D
APMIS; 2002 Sep; 110(9):639-45. PubMed ID: 12529017
[TBL] [Abstract][Full Text] [Related]
37. [Clinical analysis of 31 cases of esthesioneuroblastoma].
He X; Wang Y
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2021 Apr; 35(4):338-340. PubMed ID: 33794633
[No Abstract] [Full Text] [Related]
38. Posttreatment prognosis of patients with esthesioneuroblastoma.
Kane AJ; Sughrue ME; Rutkowski MJ; Aranda D; Mills SA; Buencamino R; Fang S; Barani IJ; Parsa AT
J Neurosurg; 2010 Aug; 113(2):340-51. PubMed ID: 20345216
[TBL] [Abstract][Full Text] [Related]
39. Long-Term Prognostic Analysis after Endoscopic Endonasal Surgery for Olfactory Neuroblastoma: A Retrospective Study of 13 Cases.
Zhang L; Niu K; Zhu K; Xia C; Yan J; Zhao W; Wei J; Duan M; Zheng G
PLoS One; 2016; 11(11):e0166046. PubMed ID: 27806104
[TBL] [Abstract][Full Text] [Related]
40. Comparison of outcomes for open versus endoscopic approaches for olfactory neuroblastoma: A systematic review and individual participant data meta-analysis.
Fu TS; Monteiro E; Muhanna N; Goldstein DP; de Almeida JR
Head Neck; 2016 Apr; 38 Suppl 1():E2306-16. PubMed ID: 26514662
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
